NEW YORK (GenomeWeb) – Startup company Viome announced today that it has raised $15 million in Series A funding to support the launch of its at-home human microbiome testing kit.

The company is currently functioning in beta mode, with thousands of customers using the product.

Viome's first round of venture capital financing was led by Khosla Ventures, with participation from Bold Capital partners. Khosla Ventures, led by managing partner Vinod Khoshla, will receive one seat on Viome's board. The company also noted it has now raised a total of $21 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.